ALPHAMAB ONCOLOGY |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.39 HKD | +0.84% |
|
-7.00% | -64.01% |
| 06-05 | ArriVent, Alphamab Unit to Collaborate on Antibody Drug Conjugates For Cancer Treatment | MT |
| 06-05 | Alphamab Strikes Deal with Nasdaq-Listed ArriVent to Co-Develop Antibody Drug Conjugates | MT |
Quotes 5-day view
Delayed Quote Hong Kong S.E.| 2024-06-20 | 2024-06-21 | 2024-06-24 | 2024-06-25 | 2024-06-25 | |
|---|---|---|---|---|---|
| Last | 2.64 $ | 2.58 $ | 2.41 $ | 2.37 $ | 2.39 $ |
| Volume | 3 837 000 | 3 757 000 | 6 818 000 | 6 618 000 | 959 000 |
| Change | -2.94% | -2.27% | -6.59% | -1.66% | +0.84% |
| Opening | 2.68 | 2.61 | 2.59 | 2.45 | 2.35 |
| High | 2.80 | 2.66 | 2.59 | 2.45 | 2.4 |
| Low | 2.62 | 2.50 | 2.40 | 2.31 | 2.35 |
Performance
| 1 day | +0.84% | ||
| 1 week | -7.00% | ||
| Current month | -5.91% | ||
| 1 month | -50.31% | ||
| 3 months | -47.12% | ||
| 6 months | -61.76% | ||
| Current year | -64.01% | ||
| 1 year | -66.67% | ||
| 3 years | -90.74% |
Volumes
marketsDaily volume
959 000
Estimated daily volume
1 776 207
Avg. Volume 20 sessions
13 208 507
Daily volume ratio
0.13
Avg. Volume 20 sessions HKD
31 568 331.73
Avg. Volume 20 sessions USD
4 042 451.15
Record volume 1
115 582 000
Record volume 2
90 680 200
Record volume 3
78 953 000
Capital turnover ratio
0.01
Float rotation
0.03
Basic data
Capitalization (HKD)
2 127 814 153
Capitalization (USD)
292 838 295
Net sales (CNY)
218 774 000
Net sales (USD)
30 108 553
Number of employees
435
Sales / Employee (CNY)
502 929
Sales / Employee (USD)
69 215
Free-Float
49.21 %
Free-Float capitalization (HKD)
1 047 167 583
Free-Float capitalization (USD)
144 115 391
Average Daily Capital Traded
1.48%
Highs and lows
1 week
2.35
2.80
1 month
2.004.89
Current year
2.006.71
1 year
2.0013.46
3 years
2.0028.70
5 years
2.0028.70
10 years
2.0028.70
Indicators
Moving average 5 days
2.54
Moving average 20 days
2.75
Moving average 50 days
3.97
Moving average 100 days
4.30
Price spread / (MMA5)
+6.44%
Price spread / (MMA20)
+15.10%
Price spread / (MMA50)
+66.27%
Price spread / (MMA100)
+79.99%
STIM
RSI 9 days
25.51
RSI 14 days
28.10
Sector Comparison - Other Biotechnology & Medical Research
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +0.84% | -7.00% | -64.01% | -66.67% | 293M | ||
| +0.44% | +3.25% | +38.36% | +16.12% | 52.73B | ||
| -0.72% | +1.38% | +36.73% | -7.32% | 39B | ||
| -1.25% | -0.66% | -8.63% | -1.23% | 38.52B | ||
| +7.74% | +56.08% | +25.46% | +24.63% | 30.38B | ||
| +1.07% | -0.44% | -11.17% | +9.21% | 26.39B | ||
| -0.44% | -0.99% | +11.44% | +39.38% | 26.08B | ||
| +0.03% | +4.25% | +45.09% | +43.48% | 14.15B | ||
| -0.15% | +1.11% | +32.93% | +82.40% | 12.6B | ||
| -1.91% | -1.97% | -5.30% | -4.63% | 11.51B | ||
| -1.65% | -1.63% | -12.69% | -0.68% | 10.63B | ||
| -2.36% | -6.19% | -8.34% | -12.04% | 9.1B | ||
| -0.32% | +1.87% | +21.62% | +4.56% | 6.63B | ||
| +0.42% | -0.15% | +15.51% | +66.95% | 6.67B | ||
| +5.19% | +15.65% | -7.10% | +18.57% | 6.85B | ||
| +0.86% | +2.94% | +35.39% | +52.16% | 6.41B | ||
| Average | +0.49% | +4.19% | +9.08% | +16.56% | ||
| Weighted average by Cap. | +0.60% | +6.68% | +17.07% | +16.57% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
231934894359.i5QMZwJ_cXVO9oHK9Kdyr7Wwh0mV47KhmDSygPYf2xk.76BaSnhPAUAdmPKGxd0Ww_TVwXzsmoTW0mbj4qdci3z-_1gteEsyKj-f4g
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 23:58:21 | 2.39 | 1,000 | 894,000 |
| 23:53:40 | 2.39 | 34,000 | 893,000 |
| 23:53:40 | 2.39 | 3,000 | 859,000 |
| 23:53:39 | 2.38 | 5,000 | 856,000 |
| 23:53:39 | 2.38 | 1,000 | 851,000 |
| 23:53:39 | 2.38 | 25,000 | 850,000 |
| 23:53:39 | 2.38 | 10,000 | 825,000 |
| 23:49:54 | 2.38 | 2,000 | 815,000 |
| 23:49:53 | 2.38 | 1,000 | 813,000 |
| 23:44:45 | 2.37 | 4,000 | 812,000 |
Monthly variations
Annual change
| 2024 | -64.31% | ||
| 2023 | -38.52% | ||
| 2022 | -20.59% | ||
| 2021 | -16.46% | ||
| 2020 | +16.29% | ||
| 2019 | +3.70% |
- Stock Market
- Equities
- 9966 Stock
- Quotes Alphamab Oncology
